Latest News and Press Releases
Want to stay updated on the latest news?
-
FSR Global Virtual Sarcoidosis Summit - June 28-29 - is the world’s largest online sarcoidosis event.
-
NEW YORK, May 23, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
-
Coalition to Transform Clinical Trial Engagement (CTCTE) announces launch of Champions for Change – Paid Time Off (PTO) Initiative.
-
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
-
NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
-
BUENOS AIRES, Argentina, April 16, 2025 (GLOBE NEWSWIRE) -- Biosidus, an Argentinean pioneer company in biotechnology research, development, and the production of high-quality biosimilars, has...
-
Austin, TX, USA, March 27, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Fabry Disease Treatment Market Size, Trends and Insights By Treatment (Enzyme...
-
February is American Heart Month - Expert with Bayer Discusses Key Risk Factors for Heart Disease and Shares Practical Tips for Improving Heart Health NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- ...
-
February is American Heart Month - Expert with Bayer Discusses Key Risk Factors for Heart Disease and Shares Practical Tips for Improving Heart Health NEW YORK, Feb. 24, 2025 (GLOBE NEWSWIRE) --...
-
NEW YORK, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...